Revatio, Viagra (sildenafil) is a small molecule pharmaceutical. Sildenafil was first approved as Revatio on 1998-03-27. It is used to treat pulmonary hypertension and vasculogenic impotence in the USA. It has been approved in Europe to treat erectile dysfunction and pulmonary hypertension. The pharmaceutical is active against cGMP-specific 3',5'-cyclic phosphodiesterase. In addition, it is known to target solute carrier organic anion transporter family member 1B3, cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha', solute carrier organic anion transporter family member 2B1, and multidrug resistance-associated protein 5.
|Trade Name||Revatio, Viagra|
|Indication||erectile dysfunction, pulmonary hypertension, vasculogenic impotence|
|Drug Class||Pde5 inhibitors|